Dongsian improved new drug phosphate estaphate slow release tablets declared clinical

Oseltamivir is a specific inhibitor of neural anase that inhibits the spread of mature influenza viruses away from host cells, thereby suppressing the spread of influenza viruses in the body to treat influenza.
Ostaway's original research manufacturer is Roche, the product named Duffy, in 2001 Ottawe capsules were approved in China;
Sunshine is the largest market share share of Estave, which currently has two dosage forms, estave capsules and particles.
July, Dongsan also submitted an application for the listing of Ostave dry suspension, which is currently under review and approval, according to the Company's Insight database.
this declaration of clinical release tablets for the East Sunshine Estave declaration of the fourth dosage form, is conducive to strengthening the East Sunshine market share control of Estave.
Currently approved domestic estave preparations and market share (Insight finishing) According to Insight database statistics, Estave capsules have 9 enterprises submitted applications for listing, 9 enterprises are in the BE trial stage;
from the Insight database () It is worth noting that on September 27 this year, Beijing Xingxuan Pharma submitted an application for the listing of a new class 2.2 modified drug called esotamitaxine.
。